Abbott Repatriation Could Fund Foreign Operation Building
This article was originally published in The Tan Sheet
Abbott is eyeing foreign expansion as it weighs repatriating up to $4 bil. in foreign earnings this fiscal year
You may also be interested in...
EAS has emerged as a strong contributor to Abbott's Ross adult nutritionals business
Perrigo promotes in pricing, planning
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC